Dave Lawrence

Dave Lawrence, MBA, joined the NeuroTrauma Sciences leadership team in March 2021 as Chief Financial Officer. Dave has over 20 years of financial and operational leadership experience in the biotechnology industry. At Acorda Therapeutics he served in the role of several financial and operating positions including Chief, Business Operations and Principal Accounting Officer, as well as Chief Financial Officer and VP of Finance. While at Acorda, Dave managed the successful completion of the company’s IPO and managed several follow-on offerings and private placements raising a total of over $700 million. His prior experience includes financial management positions of Vice President and Controller and Finance Manager for several telecommunications companies including Tel-Air Communications, Southwestern Bell and Metromedia Telecommunications.

Dave received his B.A. in Accounting from Roger Williams College and an M.B.A. in Finance from Iona College. He was a founding member and served on the Board of Directors as Treasurer for the Brian Ahearn Children’s Fund, a 501(c)(3) charitable organization and currently serves as Chair of the BIO Business Solutions Advisory Board.